20
By: SHARIFAH MAZRAH SAYED MOHAMED ZAIN 9 Jun 2015 Occupa&onal Health Unit Environmental Health Research Centre Ins&tute for Medical Research

SHARIFAH MAZRAH SAYED MOHAMED ZAINnehapmalaysia.moh.gov.my/wp-content/uploads/2016/03/Paper-Scie… · By: SHARIFAH MAZRAH SAYED MOHAMED ZAIN 9 Jun 2015 Occupaonal Health Unit Environmental

  • Upload
    others

  • View
    6

  • Download
    0

Embed Size (px)

Citation preview

By:

SHARIFAHMAZRAHSAYEDMOHAMEDZAIN

9Jun2015

Occupa&onalHealthUnitEnvironmentalHealthResearchCentre

Ins&tuteforMedicalResearch

Presenta&onOutline

•  Introduc&on•  Objec&ve• Methodology•  Results•  Conclusion

Introduc&onFormaldehydesymptomsofhumanexposure(ACUTEEFFECT)byIARC,1979:1.  Irrita&onofeyes2.  Tightchest3.  Burnsinnoseandthroat4.  ShortnessofbreathFormaldehydeisclassifiedasacarcinogen(CHRONICEFFECT):1.   Known human and animal carcinogen causing nasopharyngeal cancer

byInterna&onalAgencyforResearchonCancer(IARC)2004.2.   CarcinogenictohumansbyWorldHealthOrganiza&on(WHO).3.   Class A2 (suspected for human) by the American Conference of

GovernmentalIndustrialHygienists(ACGIH).4.   Probablehumancarcinogen(GroupB1)byUnitedStatesEnvironmental

Protec&onAgency(USEPA).

5.  Sleeplessness6.  Nausea7.  Derma&&s8.  Sneezing

Introduc&on�  Formaldehyde listed as one of the Common Chemicals Used InHospital as “a fixa've in histopathology specimens in mostlaboratoriesandinmorguestopreservedeadbodies”.

�  “Personnelworking in thePathology,PharmacologyandRadiologyDepartmentsareathigherriskofexposuretochemicals”.

�  “Poormanagementofchemicalscanleadtooccupa'onaldiseases,poisoningandcancers”.

(GuidelinesonChemicalManagementinHealthCareFacili'esMinistryofHealth,

QualityinMedicalCareSec'on,MedicalDevelopmentDivision,MOH,2010)

Objec&veTo evaluate the formaldehyde exposurelevel and its symptoms among healthcareworkers in histopathology laboratories whowereexposedtoformaldehydeascomparedtothenon-exposedworkers.

SamplingMethodologyResearchDesign:Compara&vecrosssec&onalstudywithcomparisongroup(exposedandunexposed):1.Ques&onnaire2.Airsampling(TWA8&STEL15min)StudyGroup:1.  19respondentsfromexposedgroup:workersinhistopathologylab.2.  71respondentsfromunexposedgroup:workersinthe

administra&ondepartment.SampleSite(GovernmentHospitalinKlangValley):1.  Hospital1:24th–26thMarch20152.  Hospital2:7th–9thApril2015

SamplingMaterials

SKCpumppouchSamplingpumpAirChek5000

Collarclip

Tripod

SorbenttubesSKC226-117

TubebreakerSKC222-3-50

Tygontubing TripodAirflowcalibrator

FormaldehydeSamplingMethodTWA8

TWA8

8-hrTimeWeightedAverageSamplingarea

Ambientworkplaceofexposedandnon-exposed(LabandAdmin)

Time 8.30amto4.30pm

Flowrate 0.1L/min

Airvol. 24L

Dura\on 4hourspersamplingx2&mes

Procedure Airsamplescollectedusingpersonalsamplingpumpbydrawing24LofairthroughsamplingtubescontainingXAD-2adsorbent-coatedwith2-(hydroxymethyl)piperidine.

Reference USOSHASamplingandAnaly&calMethods:Acroleinand/orFormaldehyde,52

Tygontubing

Samplingpump

FormaldehydeSamplingMethodSTELSTEL

15minShortTermExposureLimitSamplingarea

Atbreathingzoneofexposedworkers(Labworkersonly)

Time 8.30amto4.30pm(whenexposed)

Flowrate 0.2L/min

Airvol. 3L

Dura\on 15minpersampling

Procedure Airsamplescollectedusingpersonalsamplingpumpbydrawing3LofairthroughsamplingtubescontainingXAD-2adsorbent-coatedwith2-(hydroxymethyl)piperidine.

Reference USOSHASamplingandAnaly&calMethods:Acroleinand/orFormaldehyde,52

Tygontubing

Samplingpump

AnalysisMethod

GCColumncapillary,30mx0.32mmODx0.5µmfilm,DB-Wax

Sorbentstransferredto2mLvial

1mLoftolueneisaddedineachvial

Vialsagitatedinultrasonicwaterbathfor60min

AnalyseusingGasChromatography,FID

TWA8FormaldehydeExposure

*IndustryCodeofPrac&ceonIndoorAirQuality2010,DepartmentofOccupa&onalSafetyandHealthMalaysia

TWA8 0.1ppm

USOSHAPermissibleExposureLimit(PEL)–GeneralIndustry TWA8 0.75ppmNa&onalIns&tuteforOccupa&onalsafetyandHealth(NIOSH)RecommendedExposureLimit TWA 0.016ppmAmericanConferenceofGovernmentalIndustrialHygienist(ACGIH)2007 TLV 0.3ppmOccupa&onalSafetyandHealth(UseandStandardsofExposureofChemicalsHazardoustoHealth)Regula&ons,OSHA1994

C 0.3ppm

0.241

0.154

0.116

0.055

0.000

0.050

0.100

0.150

0.200

0.250

0.300

Hosp.1 Hosp.2

HistopathologyLab Administra&onDept.

Form

alde

hyde

con

c,ppm

15minSTELFormaldehydeExposure

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

S01 S02 S03 S04 S05 S06 S07 S08 S09 S10 S11 S12 S13 S14 S15 S16 S17 S18 S19

Form

alde

hyde

con

centra&o

nSTEL(p

pm)

Std1:USOSHAPermissibleExposureLimit(PEL)–GeneralIndustry

Std2:Na&onalIns&tuteforOccupa&onalSafetyandHealth(NIOSH)–RecommendedExposureLimit

Std.1

Std.2

Symptoms

30 30.0

60.0 60.0

30.0

0.0

20.0 22.9

34.3

11.4

0

10

20

30

40

50

60

70

80

90

Chest&ghtness

Runnynose

DrowsinessHeadache Rednessofeyes

Exposed Nonexposed

Percen

tage

11.1

33.3

77.8

22.2

44.4

5.7

20.025.7

20.017.1

0

10

20

30

40

50

60

70

80

90

Chest&ghtness

RunnynoseDrowsiness Headache Rednessofeyes

Exposed Nonexposed

Percen

tage

HOSP.1 HOSP.2

Conclusion�  TheTWA8andSTEL-belowtheUnitedStateOccupa&onalSafetyandHealthAdministra&on(USOSHA)standardof0.75ppmand2ppm,respec&vely.

� Althoughtheconcentra&onswereundertheUSOSHAlimit,presenceofsymptomssuggestsignificantexposureandfurthercontrolmeasuresareneededtoimproveindoorairqualityandtoensureworker’shealth.

THANK YOU…